NervGen Pharma nervgenpharma.com

NervGen Pharma creates solutions for the treatment of nerve damage. NervGen's core technology focuses on the protein tyrosine phosphatase sigma (PTPσ), a key neural receptor that inhibits nerve regeneration resulting in a loss of function in patients with spinal cord injury and other medical conditions. Inhibition of the PTPσ receptor has been shown to promote regeneration of damaged nerves and improvement of nerve function in animal models for various medical conditions. A series of receptor ...Show all

NervGen Pharma creates solutions for the treatment of nerve damage. NervGen's core technology focuses on the protein tyrosine phosphatase sigma (PTPσ), a key neural receptor that inhibits nerve regeneration resulting in a loss of function in patient...Show all

Company (IPO / Went public)

All investors data 1 Investors

• Undisclosed Investors